Brief: Moberg Pharma Q4 EBIT Loss Narrows To SEK 4.9 Million
Feb 8 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* Q4 EBITDA SEK -4.2 MILLION (-5.3)
* Q4 OPERATING PROFIT (EBIT) SEK -4.9 MILLION (-6.0)
* Q4 PROFIT AFTER TAX SEK -4.0 MILLION (-5.7)
Source text for Eikon: ID:nWkr9CcJxN
Further company coverage: MBPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains